A feed composition for ruminants may include feed particles that contain a saturated fatty acid component as well as a urease inhibitor such that ingestion of the feed by lactating ruminants may provide for an increase in the amount of milk produced by the ruminant and/or an increase in the fat content of the milk produced, and a decrease in ammonia production from breakdown of urea.

The present invention provides a controlling agent for a disease caused by a Clostridium bacterium, comprising a cashew nut shell liquid, a heat-treated cashew nut shell liquid, anacardic acid, cardanol, or anacardic acid and cardanol.

The present invention provides a controlling agent for a disease caused by a Clostridium bacterium, comprising a cashew nut shell liquid, a heat-treated cashew nut shell liquid, anacardic acid, cardanol, or anacardic acid and cardanol.

The present disclosure relates to a granular feed additive capable of reducing hygroscopicity and lumping and caking, the additive including a basic amino acid and an anion represented by Formula 1, wherein a molar ratio of the anion to the basic amino acid is greater than 0.1 and equal to or less than 0.52.

An organic waste digester system is provided. The system includes a heated hopper unit within the housing to receive organic waste. An agitation mechanism mixes the organic waste along with a microbe mixture to aid breakdown of the waste. Liquefied organic waste is discharged through an outlet and conveyed to a drying unit downstream of the hopper unit. The drying unit includes a microwave dryer unit.

An organic waste digester system is provided. The system includes a heated hopper unit within the housing to receive organic waste. An agitation mechanism mixes the organic waste along with a microbe mixture to aid breakdown of the waste. Liquefied organic waste is discharged through an outlet and conveyed to a drying unit downstream of the hopper unit. The drying unit includes a microwave dryer unit.

The invention relates to new isolated Lactobacillus strains chosen from Lactobacillus mellifer Bin4N.sup.T (LMG P-28344) and Lactobacillus apinorum Fhon13N.sup.T (LMG P-28345), which have been isolated from honeybees or their processed food. The bacterial strains have unique properties such as production of benzene, free fatty acids and 2-heptanone, rendering them useful in many areas such as in food and beverage products, feed products and medical products.

The invention relates to new isolated Lactobacillus strains chosen from Lactobacillus mellifer Bin4N.sup.T (LMG P-28344) and Lactobacillus apinorum Fhon13N.sup.T (LMG P-28345), which have been isolated from honeybees or their processed food. The bacterial strains have unique properties such as production of benzene, free fatty acids and 2-heptanone, rendering them useful in many areas such as in food and beverage products, feed products and medical products.

Provided are uses of Bacteroides in preparation of a medicament. The medicament is for use in treatment or prevention of obesity and obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an animal feed that comprise Bacteroides, uses thereof in treatment or prevention of obesity and obesity-related diseases, and a method for treatment or prevention of obesity and obesity-related diseases.

Provided are uses of Bacteroides in preparation of a medicament. The medicament is for use in treatment or prevention of obesity and obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an animal feed that comprise Bacteroides, uses thereof in treatment or prevention of obesity and obesity-related diseases, and a method for treatment or prevention of obesity and obesity-related diseases.